1. Home
  2. ALVR vs CRWS Comparison

ALVR vs CRWS Comparison

Compare ALVR & CRWS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALVR
  • CRWS
  • Stock Information
  • Founded
  • ALVR 2013
  • CRWS 1957
  • Country
  • ALVR United States
  • CRWS United States
  • Employees
  • ALVR N/A
  • CRWS N/A
  • Industry
  • ALVR Biotechnology: Biological Products (No Diagnostic Substances)
  • CRWS Textiles
  • Sector
  • ALVR Health Care
  • CRWS Consumer Discretionary
  • Exchange
  • ALVR Nasdaq
  • CRWS Nasdaq
  • Market Cap
  • ALVR 48.8M
  • CRWS 44.3M
  • IPO Year
  • ALVR 2020
  • CRWS N/A
  • Fundamental
  • Price
  • ALVR $9.63
  • CRWS $4.17
  • Analyst Decision
  • ALVR
  • CRWS
  • Analyst Count
  • ALVR 0
  • CRWS 0
  • Target Price
  • ALVR N/A
  • CRWS N/A
  • AVG Volume (30 Days)
  • ALVR 22.4K
  • CRWS 16.4K
  • Earning Date
  • ALVR 03-14-2025
  • CRWS 02-12-2025
  • Dividend Yield
  • ALVR N/A
  • CRWS 7.68%
  • EPS Growth
  • ALVR N/A
  • CRWS N/A
  • EPS
  • ALVR N/A
  • CRWS 0.24
  • Revenue
  • ALVR N/A
  • CRWS $86,602,000.00
  • Revenue This Year
  • ALVR N/A
  • CRWS N/A
  • Revenue Next Year
  • ALVR N/A
  • CRWS N/A
  • P/E Ratio
  • ALVR N/A
  • CRWS $17.66
  • Revenue Growth
  • ALVR N/A
  • CRWS N/A
  • 52 Week Low
  • ALVR $7.96
  • CRWS $4.16
  • 52 Week High
  • ALVR $24.15
  • CRWS $5.79
  • Technical
  • Relative Strength Index (RSI)
  • ALVR 45.63
  • CRWS 22.81
  • Support Level
  • ALVR $9.55
  • CRWS $4.22
  • Resistance Level
  • ALVR $10.41
  • CRWS $4.27
  • Average True Range (ATR)
  • ALVR 0.44
  • CRWS 0.08
  • MACD
  • ALVR 0.05
  • CRWS -0.03
  • Stochastic Oscillator
  • ALVR 22.77
  • CRWS 1.28

About ALVR AlloVir Inc.

AlloVir Inc is a late clinical-stage cell therapy company. The company focuses on developing innovative allogeneic T-cell therapies to combat viral diseases. Their proprietary VST therapy platform enables the creation of off-the-shelf VSTs, addressing the urgent medical need for treating patients with limited viral disease treatment options. With a singular focus on research, development, and commercialization, the company's platform targets 11 devastating viruses, with posoleucel being the lead candidate addressing six viruses. Operating within one segment, the company is dedicated to preventing and treating severe viral-associated diseases through off-the-shelf VST therapies.

About CRWS Crown Crafts Inc

Crown Crafts Inc operates in the infant and toddler products segment of the consumer products industry through its wholly-owned subsidiaries. The infant and toddler products segment consists of infant and toddler bedding, bibs, soft bath products, disposable products, and accessories. The company serves a diverse range of customers including mass merchants, mid-tier retailers, juvenile specialty stores, value channel stores, grocery and drug stores, restaurants, internet accounts, wholesale clubs, and internet-based retailers. The company's brands include NoJo, Neat Solutions, Sassy, and Carousel. Its products are marketed under a variety of company-owned trademarks, under trademarks licensed from others, and as private-label goods.

Share on Social Networks: